| In vitro dissolution as a tool for formulation selection: telmisartan two-step IVIVC A Ruiz Picazo, MT Martinez-Martinez, S Colón-Useche, R Iriarte, ... Molecular pharmaceutics 15 (6), 2307-2315, 2018 | 41 | 2018 |
| Exploring bioequivalence of dexketoprofen trometamol drug products with the gastrointestinal simulator (GIS) and precipitation pathways analyses M Bermejo, G Kuminek, J Al-Gousous, A Ruiz-Picazo, Y Tsume, ... Pharmaceutics 11 (3), 122, 2019 | 27 | 2019 |
| Comparison of segmental-dependent permeability in human and in situ perfusion model in rat A Ruiz-Picazo, I Lozoya-Agullo, M Ortiz-Azcarate, M Merino-Sanjuán, ... European Journal of Pharmaceutical Sciences 107, 191-196, 2017 | 25 | 2017 |
| In vitro prediction of in vivo absorption of ibuprofen from suspensions through rational choice of dissolution conditions M Hofmann, MA García, J Al-Gousous, A Ruiz-Picazo, F Thieringer, ... European Journal of Pharmaceutics and Biopharmaceutics 149, 229-237, 2020 | 23 | 2020 |
| Determination of intestinal permeability using in situ perfusion model in rats: Challenges and advantages to BCS classification applied to digoxin TG Caldeira, A Ruiz-Picazo, I Lozoya-Agullo, DA Saúde-Guimarães, ... International Journal of Pharmaceutics 551 (1-2), 148-157, 2018 | 21 | 2018 |
| Level A IVIVC for immediate release tablets confirms in vivo predictive dissolution testing for ibuprofen I Cámara-Martinez, JA Blechar, A Ruiz-Picazo, A Garcia-Arieta, ... International Journal of Pharmaceutics 614, 121415, 2022 | 15 | 2022 |
| Effect of excipients on oral absorption process according to the different gastrointestinal segments A Ruiz-Picazo, I Lozoya-Agullo, I González-Álvarez, M Bermejo, ... Expert Opinion on Drug Delivery 18 (8), 1005-1024, 2021 | 15 | 2021 |
| Effect of common excipients on intestinal drug absorption in wistar rats A Ruiz-Picazo, M Gonzalez-Alvarez, I Gonzalez-Alvarez, M Bermejo Molecular Pharmaceutics 17 (7), 2310-2318, 2020 | 15 | 2020 |
| An in vivo predictive dissolution methodology (iPD methodology) with a BCS class IIb drug can predict the in vivo bioequivalence results: etoricoxib products I Gonzalez-Alvarez, M Bermejo, Y Tsume, A Ruiz-Picazo, ... Pharmaceutics 13 (4), 507, 2021 | 14 | 2021 |
| Investigation to explain bioequivalence failure in pravastatin immediate-release products A Ruiz-Picazo, S Colón-Useche, B Perez-Amorós, M González-Álvarez, ... Pharmaceutics 11 (12), 663, 2019 | 12 | 2019 |
| Saúde-Guimarães DA, González-Álvarez M., de Souza J., González-Álvarez I., Bermejo M. Determination of intestinal permeability using in situ perfusion model in rats: Challenges … TG Caldeira, A Ruiz-Picazo, I Lozoya-Agullo Int. J. Pharm 551, 148-157, 2018 | 11 | 2018 |
| Effect of thickener on disintegration, dissolution and permeability of common drug products for elderly patients A Ruiz-Picazo, S Colón-Useche, M Gonzalez-Alvarez, I Gonzalez-Alvarez, ... European Journal of Pharmaceutics and Biopharmaceutics 153, 168-176, 2020 | 9 | 2020 |
| pH-Dependent Molecular Gate Mesoporous Microparticles for Biological Control of Giardia intestinalis I Gonzalez-Alvarez, V Vivancos, C Coll, B Sánchez-Dengra, E Aznar, ... Pharmaceutics 13 (1), 94, 2021 | 6 | 2021 |
| Impact on intestinal permeability of pediatric hyperosmolar formulations after dilution: Studies with rat perfusion method A Ruiz-Picazo, M Gonzalez-Alvarez, A Navarro, I Gonzalez-Alvarez, ... International Journal of Pharmaceutics 557, 154-161, 2019 | 6 | 2019 |
| Saude-Guimaraes DA, Gonzalez-Alvarez M, de Souza J, et al. Determination of intestinal permeability using in situ perfusion model in rats: Challenges and advantages to BCS … TG Caldeira, A Ruiz-Picazo, I Lozoya-Agullo International Journal of Pharmaceutics 551 (1), 148-57, 2018 | 5 | 2018 |
| Integration of in silico, in vitro and in situ tools for the preformulation and characterization of a novel cardio-neuroprotective compound during the early stages of drug … C Miranda, A Ruiz-Picazo, P Pomares, I Gonzalez-Alvarez, M Bermejo, ... Pharmaceutics 14 (1), 182, 2022 | 4 | 2022 |
| One and two-step in vitro-in vivo correlations based on USP IV dynamic dissolution applied to four sodium montelukast products M Prieto-Escolar, JJ Torrado, C Álvarez, A Ruiz-Picazo, ... Pharmaceutics 13 (5), 690, 2021 | 4 | 2021 |
| One and two-step in vitro-in vivo correlations based on USP IV dynamic dissolution applied to four sodium montelukast products. Pharmaceutics. 2021; 13 M Prieto-Escolar, JJ Torrado, C Álvarez, A Ruiz-Picazo, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 3 | 2021 |
| Pharmaceutical Compounding in Veterinary Medicine: Suspension of Itraconazole GJ Cabañero-Resta, B Sánchez-Dengra, A Ruiz-Picazo, M Bermejo, ... Pharmaceutics 16 (5), 576, 2024 | 2 | 2024 |
| Exploring a bioequivalence failure for silodosin products due to disintegrant excipients I González-Álvarez, B Sánchez-Dengra, R Rodriguez-Galvez, ... Pharmaceutics 14 (12), 2565, 2022 | 2 | 2022 |